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Abstract 
Background: We proposed a method of using electrical stimulation for treatment of malignant melanoma through 
directly spray-printing liquid metal on skin as soft electrodes to deliver low intensity, intermediate frequency electric 
fields.
Methods: With patterned conductive liquid metal components on mice skin and under assistance of a signal gen-
erator, a sine wave electrical power with voltage of 5 V and 300 kHz could be administrated on treating malignant 
melanoma tumor.
Findings: The experiments demonstrated that tumor volume was significantly reduced compared with that of the 
control group. Under the designed parameters (signal: sine wave, signal amplitude Vpp: 5 V and Vpp: 4 V, frequency: 
300 kHz) of Tumor treating fields (TTFields) with the sprayed liquid metal electrode, four mice tumor groups became 
diminishing after 1 week of treatment. The only device-related side effect as seen was a mild to moderate contact 
dermatitis underneath the field delivering electrodes. The SEM images and pathological analysis demonstrated 
the targeted treating behavior of the malignant melanoma tumor. Further, thermal infrared imaging experiments 
indicated that there occur no evident heating effects in the course of treatment. Besides, the liquid metal is easy to 
remove through medical alcohol.
Conclusions: Tumor treating fields through liquid metal electrode could offer a safe, straightforward and effective 
treatment modality which evidently slows down tumor growth in vivo. These promising results also raised the pos-
sibility of applying spray-printing TTFields as an easy going physical way for future cancer therapy.
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Background
As living cells consist of ions, polar or charged molecules, 
membranes and organelles, they are responsive to and 
often generate electric fields and currents. The electric 
activity of cells plays a key role in many essential bio-
logical processes. Low intensity, intermediate frequency, 
electric fields have been proved to inhibit cancerous cell 
growth in  vitro by an anti-microtubule mechanism of 
action. However, the classical electrical treatment devices 
are generally rigid circuit microelectronics which may 
sometimes encounter troubles such as poor coupling 
performance and large contact comfortableness etc. 
Under the huge contact resistance thus induced between 
circuits and skin, the nearby tissues may easily subject 
to hurt due to extremely high electrical voltage. On the 
other hand, such electrodes may cause discomfort and 
even hurt to human body due to their mechanically rigid 
fixing property. Recently, the flexible electronics (electri-
cal or composite inks) is increasingly investigated and 
gradually applied to bio-electronic measurement [1–5]. 
However, a tough issue lying behind such composite 
inks [6–8] is that they rely heavily on the high tempera-
ture annealing or other more complex process such as 
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evaporation. Besides, these electronic inks’ conductive 
performance is still not good enough for practical use. As 
an alternative, the recently emerging room temperature 
liquid metal is easy to manufacture electronics directly 
on flexible substrates even skin with unique convenience 
[9–14]. However, most of the currently available printing 
methods could not fabricate the electrical components 
on skin, whose geometry is generally irregular and not 
easy to deposit a circuit. Recently, we proposed an effi-
cient approach of using the atomized spraying method 
to directly print the room temperature liquid metal to 
fabricate electronics on skin at room temperature which 
does not request a thermal annealing process [15]. Here, 
we extend this technology into a quick and direct manu-
facturing tool to pattern electrical components on skin to 
tackle tumor diseases for the first time.
Methods
Treatment method
According to Fig.  1, the current therapy for treating 
malignant melanoma tumor depends on the soft liquid 
metal electrodes and electrical fields delivered into the 
target site. To test the effectiveness of our method in 
destroying tumor cells in  vivo, an animal tumor model 
of C57BL/6 mice inoculated intradermally with malig-
nant melanoma cells (B16F10) was particularly adopted. 
Tumor treating fields (TTField) was administrated by 
means of 15-mm-long insulated wire needle (outer 
diameter, 0.3  mm; insulation thickness, 0.1  mm; Tefzel) 
inserted intradermally on one side of the tumor, then liq-
uid metals were sprayed on the surface of the tumor, leav-
ing only 4 cm2 normal skin on the other side of the tumor. 
Another identical wire needle was inserted intradermally 
into the 4 cm2 normal skin left on the other side of the 
tumor. TTFields were generated between liquid metals 
plus inserted (intradermal) wholly insulated wire needle 
placed on one side of the tumor and inserted (intrader-
mal) wholly insulated wire needle placed on the other 
side of the tumor. Mice with inserted electrodes were 
treated 90 min per day for 6 days beginning 1 week after 
cell inoculation. The animal study has been approved by 
the Ethics Committee of Tsinghua University, Beijing, 
China under contract [SYXK (Jing) 2009-0022].
Experimental design
Eight healthy C57/BL mice (Purchased from Beijing 
Weitong Lihua experimental animal center) were tested, 
whose subcutaneous skin were inoculated with mela-
noma B16 tumor cell lines.
After 14 days, the mice were divided into two groups: 
six mice in the experimental group and two mice in the 
control group. The experimental group was divided into 
three experimental groups with different test conditions: 
(A) Electrical stimulation parameters of mice model 
(signal: sine wave, signal amplitude Vpp: 5 V, frequency: 
300  kHz); (B) (signal: sine wave, signal amplitude Vpp: 
5 V, frequency: 100 kHz) and (C) (signal: sine wave, sig-
nal amplitude Vpp: 4 V, frequency: 300 kHz) respectively. 
Each group has 2 mice. The mice in the control group 
were sprayed with liquid metal electrodes on the surface 
of the tumor, leaving only 4 cm2 normal skin on the other 
side of the tumor without TTFields. The sine wave signal 
of TTFields through the electrode was administrated by 
means of 15-mm-long insulated wire needle. Mice were 
treated with TTFields 90 min per day for 6 days.
In the control group, the mice were also sprayed with 
liquid metals electrodes, with the same time length and 
interval of treatment without TTFields. Percutaneous 
measurements were made on tumor volume in eight 
mice, in the treatment of the beginning of the first 1d, 2d, 
6d and 7d. Tumor volume can be calculated via formula: 
V =  (a × b2)/2, where a is the longest diameter of the 
tumor and b is the longest perpendicular diameter length 
of a.
After 6  days of complete electrical stimulation treat-
ment, in each group a mouse was sacrificed. The tumor 
tissues were removed and fixed with 10  % formalin for 
histopathological examination. Magnetic resonance 
imaging (MRI) examination was performed 24 h after the 
TTFields treatment with sprayed liquid metals electrodes 
removed by ethanol.
Results
The average volume of the three experimental groups 
and control group tumor are presented in the following 
Table 1.
Fig. 1 Principle of using liquid metal electrodes to deliver electrical 
stimulation for tumor therapy
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Treatment outputs
Through in  vivo treatment of tumors in C57BL/6 
(B16F10 syngeneic tumor model), significant slowing of 
tumor growth and extensive destruction of tumor cells 
were obtained within 6 days. We found that 300 kHz of 
TTFields at low intensities of 5  V/cm effectively inhib-
ited malignant melanoma growth compared with other 
electrical stimulation parameters. Photographs of exam-
ples of treated mice models with 300 kHz of TTFields at 
low intensities of 5  V/cm and other electrical stimula-
tion parameters are given in (Fig. 2a–c) for comparison. 
Clearly, the sizes of the treated tumors were significantly 
smaller than that of control tumors at the end of treat-
ment. In addition, total process was found to be both 
safe and effective in slowing tumor progression. These 
findings demonstrate the potential applicability of the 
described spray-printing TTFields as a novel therapeutic 
modality for tackling malignant tumors.
Magnetic resonance imaging
Magnetic resonance imaging (MRI) data from a rep-
resentative mouse that showed an almost complete 
response to the spray-printing TTFields treatment 
is shown in Fig.  3. It indicates that, a tumor was vis-
ible before TTFields treatment (Fig. 3a) while almost no 
tumor was detected 24  h after treatment (Fig.  3b). The 
tumor volume post-treatment was significantly smaller 
than that of the pre-treatment (23 versus 197  mm3) 
(Fig. 3a, b).
Pathological results
Observed by naked eyes, after electrical stimulation ther-
apy, in the experimental group mice (A) and (C), partial 
tumor becomes necrosis 2–3 days after applied TTFields 
treatment. And the tumors display central depression, 
with uneven surface. Then a week later, new tissue was 
seen around the necrotic tissue. In the (A) group, tumor 
Table 1 Comparison of tumor volume between experimental group and control group after TTfields was applied (Mean 
value ± standard deviation)
_*:Tumor is too small to measure
Group Days after the electric field applies (d) 1 2 6 7
(A) 305.92 ± 90.88 98.5 ± 37.12 _* _*
(B) 1567.60 ± 595.60 10,518.40 ± 8331.8 21,445.31 ± 708.51 22,803.63 ± 894.53
(C) 5147.27 ± 2984.07 3515.92 ± 2100.8 _* _*
(Control) 1714.78 ± 228.72 6530.90 ± 875.10 7916.85 ± 1145.65 11,512.3 ± 1541.3
Fig. 2 Pictures of electrical stimulation treatment of malignant melanoma tumor on mice model based on liquid metal spray-printing. a Electrical 
stimulation parameters of mice model (signal: sine wave, the voltage is 5 V, the electric field strength of about 2 V/cm, the frequency is 300 kHz). b 
Electrical stimulation parameters of mice model (signal: sine wave, voltage: 5 V, the electric field strength is about 2 V/cm, the frequency is 100 kHz). 
c Electrical stimulation parameters of mice model (signal: sine wave, voltage: 4 V, the electric field strength is about 1.6 V/cm, the frequency is 
300 kHz)
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group of mice after treatment gradually reduced within 
a week and finally disappeared. In the (C) group, tumor 
group was diminishing after 1  week of treatment, but 
more slowly. In the (B) group and the control group, the 
tumor of the mice continues to grow after treatment.
As the MRI image indicates (Fig.  3a, b), a tumor was 
visible before TTFields treatment (Fig.  3a) while almost 
no tumor was detected 24 h after treatment (Fig. 3b). The 
tumor volume post-treatment was significantly smaller 
than that of the pre-treatment (197 versus 23 mm3).
In the (A) group, as shown in Fig. 4a, c, 24 h pathologi-
cal examination demonstrated that a carbide changed the 
tumor tissue on the surface of the skin and the cancer 
nests on the integrity of the structure was completely 
destroyed.
After treatment, the tumors and their adjacent tissues 
were fixated, stained with H&E and analyzed histopatho-
logically. Histopathological analysis of treated tumors 
showed extensive necrotic tissues and cellular debris. No 
damage to the surrounding tissues was detected (Fig. 4a–
f). As the SEM figure indicates (Fig. 5a–d), there were no 
damage to the nucleus in normal cells, but the nucleic 
and cytoplasmic contents were losing in tumor cells. It 
can be explained that this treatment has produced good 
output regarding targeted therapy.
Transmission electron microscopic test
To confirm the mouse mode of tumor cell death induced 
by spray-printing TTFields treatment, we performed fur-
ther transmission electron microscopic tests. Necrotic 
cell death manifested by rupture of the plasma membrane 
and loss of nuclear and cytoplasmic contents was readily 
detected using transmission electron microscopy in post-
treatment tumor. In contrast, tissues beside the tumor 
(muscle) resembled those untreated normal control, dis-
playing intact plasma membrane and preserved nuclear 
architecture (Fig.  5a–d). Thus, spray-printing TTFields 
treatment induces necrosis in melanoma cells only.
Thermal imaging images
To exclude the temperature effect in our experiments, 
infrared camera (FLIR, US) was used to monitor the tem-
perature change on the skin surface above the treated 
tumors in vivo, which showed no significant elevation in 
temperature during the period of treatment compared 
with pre and post-treatment (Fig. 6a–f). The results vali-
date the existence of a non-thermal effect during spray-
printing TTFields treatment.
Discussion and conclusion
Traditionally, oncology therapy includes chemotherapy, 
surgery and radiation, or a combination thereof. More 
recently, molecularly targeted therapy and vaccines have 
held great promise for prolonging survival and, in some 
cases, preventing cancer. Physical modalities, other than 
ionizing radiation and heating, have been systematically 
studied as cancer treatment in just the past decade. Elec-
tric fields, while being utilized in various fields of medi-
cine, had fallen into this category until very recently. In 
the past decade, antimitotic, frequency-tuned electric 
field therapy (low-intensity, intermediate-frequency 
alternating fields), also referred to as TTFields, have been 
Fig. 3 Magnetic resonance imaging (MRI). Exemplary partial radiological response to therapy in a representative mouse. a T1-weighted axial MRI 
images with pre-treatment (left panel). b 24 h after treatment (right panel)
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studied and represent a promising regional oncology 
therapy.
Tumor treating fields is a noninvasive, regional anti-
mitotic treatment modality that delivers low-intensity 
(1–3 V/cm), intermediate-frequency (100–300 kHz) and 
alternating electric fields to the tumor using transducer 
arrays placed on the skin around the region of the body 
containing the tumor. TTFields has been approved for the 
treatment of recurrent glioblastoma by the US. FDA and 
has a CE mark in Europe [16]. TTFields therapy affects 
metaphase, by disrupting mitotic spindle formation and 
anaphase, by dielectrophoretic dislocation of intracellu-
lar constituents, resulting in apoptosis. TTFields therapy 
relies on frequency tuned to specific cancer cell types. 
The antimitotic effect of TTFields therapy has been dem-
onstrated in multiple cell lines when the appropriate 
frequency was utilized. Compared with active chemo-
therapy, TTFields therapy is associated with minimal 
toxicity, better quality of life and comparable efficacy in 
recurrent glioblastoma patients. Preclinical data demon-
strate that the antimitotic effect of TTFields is intensity 
and frequency dependent and has additive or syner-
gistic activity with chemotherapy [17–19]. In addition, 
TTFields therapy has been shown to inhibit systemic 
metastases in animal models [20]. Clinical data demon-
strate comparable efficacy in recurrent glioblastoma with 
a more favorable safety profile and better quality of life 
than chemotherapy [with US Food and Drug Administra-
tion (FDA) approval in 2011].
But no matter whether they are solid electrode or the 
newly emerging skin-electronic devices, they do not 
directly contact with the skin indeed due to large contact 
Fig. 4 The pathological pictures as the mouse was subjected to electrical treatment three times after 72 h. a The picture for the case of most of 
the tumor cells was died. b The picture for the case of most of the tumor cells were apoptosis after electrical treatment based on liquid metal 
spray-printed electrodes. c The picture for the case of normal muscle tissues beside the tumor. d The enlarged picture where the tumor cells were 
apoptosis. e The enlarged picture of the tumor cells being died. f The section picture of tissue without tumor cells
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resistance. This may generate strong coupling imped-
ance with the skin. From an alternative way, the present 
work found a highly efficient method to directly pattern 
liquid metal conductive components as electrodes on 
skin through spray-printing strategy. This quick forward 
way of making flexible electronics on skin is enabled via 
stainless mask which is pre-designed via chemical etch-
ing with line width resolution of 100 µm and can be used 
to deposit desired electrical components [15].
In the present work, we have shown that spray-printing 
TTFields could evidently inhibit the growth of tumors in 
mice while causing no general side effects or local histo-
pathological damage. This demonstrated the strategy’s 
inhibitory effect in all proliferating cell types as tested, 
whereas, nonproliferating cells and tissues were unaf-
fected. Temperature measurements on the skin above 
treated tumors in vivo, showed no significant elevation in 
temperature. This indicates that this effect is nonthermal.
Our method of directly printing electronics pat-
tern TTFields therapy owns the potential to completely 
change the treatment paradigm for solid tumor oncol-
ogy, as a regional therapy that can encompass entire body 
regions, such as brain, lungs, or liver, which are the most 
common sites of solid tumor metastasis and the most 
common cause of mortality once involved. Meanwhile, 
the directly printed electronics pattern TTFields cancer 
treatment modality avoids the conventional cytotoxic 
systemic side effects and may enable chronic and con-
tinuous cancer therapy. Previous attempts to increase 
cell killing with chemotherapy through increasing dose 
density had limited success due to the cumulative toxici-
ties of high-dose chemotherapy and radiation doses are 
limited due to potential damage to surrounding normal 
tissues.
Combination of our directly printing electronics pat-
tern TTFields therapy with chemotherapy (surgery, radi-
ation) may benefit from several ways: (1) Enhanced cell 
killing by chemotherapy due to a potential synergistic 
effect; (2) Continuous cytoreductive effect by TTFields 
therapy in between chemotherapy infusions to mini-
mize tumor regrowth, DNA repair and emergence of 
drug resistance; (3) Continuous cytoreductive effect by 
TTFields therapy in between lines of chemotherapy; (4) 
Absence of overlapping toxicity; and (5) Inhibiting the 
Fig. 5 The SEM pictures as the mouse was electrically treated seven times after 168 h. a The picture of normal muscle tissues beside the tumor. b 
The picture where the tumor cell was died. c The picture where the nucleus of the tumor cell undergone fragmentation. d The picture where the 
fragmentation of the nucleus is outside of cell
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metastasis. Together, these may add up to an exponen-
tial increase in cell killing, possibly sufficient to result in 
long-term tumor regression and control.
Compared with the conventional TTFields therapy, the 
current liquid metal electrode increased the contact area 
with the skin, enhanced therapeutic effects and reduced 
conventional TTFields adverse effects. The advantages of 
this liquid metal electrode TTFields therapy is expected 
to increase acceptability and is easy for patient use in the 
near future. Optimization of the field-generating device 
in terms of size, weight and longer battery life may ena-
ble long-term carrying and continuous cancer therapy 
throughout the day.
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